Chronic disease

Explore the complexities of Chronic disease research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against Chronic disease with flcube.com.

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise
CompanyDeals

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise

Biohaven Ltd. (NYSE: BHVN) announced that it has entered into a strategic licensing and collaboration agreement with Japan's Ono Pharmaceutical Co., Ltd. (TYO: 4528). Under the agreement, Ono will obtain…

Mirxes Partners with Thailand's National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs "Cancer Moonshot 2056"

Mirxes Partners with Thailand’s National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs “Cancer Moonshot 2056”

Huadong Medicine's Doer Bio Wins NMPA Clearance to Trial DR30206 – Tri‑Target PD‑L1/VEGF/TGF‑β Fusion Protein Advances into Stage III NSCLC Consolidation Therapy

Huadong Medicine’s Doer Bio Wins NMPA Clearance to Trial DR30206 – Tri‑Target PD‑L1/VEGF/TGF‑β Fusion Protein Advances into Stage III NSCLC Consolidation Therapy

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Novartis’ Aimovig Launches in China via GBA Early Access Scheme for Migraine Treatment

Policy / Regulatory

NHSA Sets 2022 Goals for Basic Medical Insurance Funding and Reforms

CompanyDeals

ClouDr Group’s Hong Kong IPO Nets HKD 482 Million with Sanofi as Investor

CompanyDeals

Dakang Medical Secures RMB 400M in Series E Round for Hemodialysis Center Expansion

CompanyDrug

Bayer’s Kerendia Approved by China’s NMPA for Diabetic Kidney Disease

CompanyDrug

Humanwell Healthcare Wins NMPA Approval for RFUS-144 in Pain Management

CompanyDrug

Eli Lilly’s Donanemab Receives Tacit Approval for Alzheimer’s Clinical Trial in China

CompanyDeals

China NT Pharma Group Inks Licensing Deal for Orticumab in Asia

Show More